Go to Jeff Salisbury LWGate Home Page.From: "Gene Ricci" <genr@swbell.net>
Subject: [CANSLIM] HITK
Date: Sat, 26 Jul 2003 20:30:06 -0500
Next Article (by Date): Re: [CANSLIM] Extrapolation "DMC197807"
Previous Article (by Date): Re: [CANSLIM] Extrapolation Hong Hsu
Next in Thread: Re: [CANSLIM] HITK "DMC197807"
Articles sorted by: [Date]
[Author]
[Subject]
This is a multi-part message in MIME format. - ------=_NextPart_000_06F8_01C353B4.B31F56A0 Content-Type: text/plain; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable MessageIf you still own HITK there may be a light in the tunnel. Change = Wave (Tobin Smith) sent an alert to his 300,000 (?) subscribers to buy = HITK on 7/25. Looking at the chart shows that the price dropped down and = stabilized at its 200-day moving average at $23.14 before bouncing = higher. It closed at $24.88 on 7/25. Other than a possible shortfall = because of seasonal cough medicine sales I couldn't find any other bad = news. Anyone know of any other issues? Thanks, Gene I was forwarded the following; A price under $25 is a great entry point for this dual generic/diabetes play -- forget the noise from the momentum buyers-turned-sellers. They were cleaned out with the huge volume sales, so now it's time to build or add to your positions to get to a $25 cost basis. I still think we can hold on for a $50 value at the end of 2004 on $2 per share earnings in 2004. Let's lower the buy under for HITK to $25. - ------=_NextPart_000_06F8_01C353B4.B31F56A0 Content-Type: text/html; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> <HTML><HEAD><TITLE>Message</TITLE> <META http-equiv=3DContent-Type content=3D"text/html; = charset=3Diso-8859-1"> <META content=3D"MSHTML 6.00.2800.1106" name=3DGENERATOR> <STYLE></STYLE> </HEAD> <BODY bgColor=3D#ffffff> <DIV><SPAN class=3D670474503-26072003><FONT face=3D"Comic Sans MS"><FONT = size=3D4>If=20 you still own HITK there may be a light in the tunnel. Change Wave = (Tobin Smith)=20 sent an alert to his 300,000 (?) subscribers to buy HITK on = 7/25.=20 <SPAN class=3D670474503-26072003>Looking at the chart shows that = the=20 price dropped down and stabilized at its 200-day moving average at = $23.14=20 before bouncing higher. It closed at $24.88 on 7/25. Other than a = possible=20 shortfall because of seasonal cough medicine sales I couldn't find = any=20 other bad news. Anyone know of any other=20 issues?</SPAN></FONT></FONT></SPAN></DIV> <DIV><SPAN class=3D670474503-26072003><SPAN = class=3D670474503-26072003><FONT=20 face=3D"Comic Sans MS" size=3D4></FONT></SPAN></SPAN> </DIV> <DIV><SPAN class=3D670474503-26072003><SPAN = class=3D670474503-26072003><FONT=20 face=3D"Comic Sans MS" size=3D4>Thanks,</FONT></SPAN></SPAN></DIV> <DIV><SPAN class=3D670474503-26072003><SPAN = class=3D670474503-26072003><FONT=20 face=3D"Comic Sans MS" size=3D4>Gene</FONT></SPAN></DIV> <DIV><SPAN class=3D670474503-26072003><FONT face=3D"Comic Sans MS"=20 size=3D4></FONT></SPAN> </DIV> <DIV><FONT face=3D"Comic Sans MS" size=3D4>I was forwarded the=20 following;</FONT></SPAN></DIV> <DIV><SPAN class=3D670474503-26072003><FONT face=3DArial=20 size=3D2></FONT></SPAN> </DIV> <DIV><SPAN class=3D670474503-26072003><EM>A price under $25 is a great = entry point=20 for this dual<BR>generic/diabetes play -- forget the noise from the=20 momentum<BR>buyers-turned-sellers. They were cleaned out with the huge=20 volume<BR>sales, so now it's time to build or add to your positions to = get=20 to<BR>a $25 cost basis. I still think we can hold on for a $50 value = at<BR>the=20 end of 2004 on $2 per share earnings in 2004.<BR></EM><BR><EM>Let's = lower the=20 buy under for HITK to $25.</EM></SPAN></DIV> <DIV><SPAN class=3D670474503-26072003><FONT face=3DArial=20 size=3D2></FONT></SPAN> </DIV> <DIV><SPAN class=3D670474503-26072003><FONT face=3DArial=20 size=3D2></FONT></SPAN> </DIV></BODY></HTML> - ------=_NextPart_000_06F8_01C353B4.B31F56A0-- - - - -To subscribe/unsubscribe, email "majordomo@xmission.com" - -In the email body, write "subscribe canslim" or - -"unsubscribe canslim". Do not use quotes in your email.
Next Article (by Date): Re: [CANSLIM] Extrapolation "DMC197807"
Previous Article (by Date): Re: [CANSLIM] Extrapolation Hong Hsu
Next in Thread: Re: [CANSLIM] HITK "DMC197807"
Articles sorted by: [Date]
[Author]
[Subject]